In vitro vaccine potency testing: a proposal for reducing animal use for requalification testing.
This paper proposes a program under which the use of animals for requalification of in vitro potency tests could be eliminated. Standard References (USDA/CVB nomenclature) would be developed, characterized, stored and monitored by selected reference laboratories worldwide. These laboratories would employ scientists skilled in protein and glycoprotein chemistry and equipped with state-of-the-art instruments for required analyses. After Standard References are established, the reference laboratories would provide them to the animal health industry as "gold standards". Companies would then establish and validate a correlation between the Standard Reference and the company Master Reference (USDA/CVB nomenclature) using an internal in vitro assay. After this correlation is established, the company could use the Standard References for qualifying, monitoring and requalifying company Master References without the use of animals. Such a program would eliminate the need for animals for requalification of Master References and the need for each company to develop and validate a battery of Master Reference Monitoring assays. It would also provide advantages in terms of reduced costs and reduced time for requalification testing. As such it would provide a strong incentive for companies to develop and use in vitro assays for potency testing.
Pair O' Docs Consultants, Parkville, MO, USA. kkbhgb@aol.com
K
K
Brown
W
W
Stokes
D000826:Animal Testing Alternatives / Q000379:methods / Q000592:standards; D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D012015:Reference Standards; D014611:Vaccination / Q000662:veterinary*; D014612:Vaccines / Q000008:administration & dosage / Q000276:immunology*; D019155:Veterinary Drugs / Q000592:standards*; D014730:Veterinary Medicine / Q000379:methods / Q000592:standards*
D014612:Vaccines; D019155:Veterinary Drugs